Pluristyx, the leading provider of innovative induced pluripotent stem cells (iPSC), announces the issuance of the groundbreaking induced Allogeneic Cell Tolerance (iACT Stealthtm) U.S. Patent No. 12, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback